healthcare.digital September 2, 2025
Executive Summary
The global MedTech sector is entering a new era of mergers and acquisitions (M&A) characterised by a pronounced shift from broad portfolio expansion to highly selective, technology-driven acquisitions. While the broader healthcare M&A landscape experienced a decline in deal volume and value in 2024, the MedTech sub-sector demonstrated remarkable resilience. This report highlights that a period of market resurgence is underway, driven by a strategic focus on a smaller number of high-value deals. The primary catalysts for this activity are the urgent pursuit of innovations in artificial intelligence (AI), advanced surgical solutions, and digital health, as well as the imperative of market consolidation and global expansion.
This new M&A environment is not without its challenges. Dealmakers must navigate...
Today's Sponsors
Today's Sponsor